Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, China.
University of Science and Technology of China, Hefei, China.
Front Immunol. 2022 Jul 14;13:941219. doi: 10.3389/fimmu.2022.941219. eCollection 2022.
Cold atmospheric plasma has been widely applied in medical treatment clinically, especially skin diseases. However, the mechanism of cold atmospheric plasma on the treatment of skin diseases is still undefined. In this study, dinitrofluorobenzene-induced atopic dermatitis mice model was constructed. Cold atmospheric plasma was able to decrease skin cells apoptosis, relieve skin inflammation, ER stress and oxidative stress caused by dinitrofluorobenzene stimulation, which was mediated by cold atmospheric plasma-induced MANF expression. In terms of mechanism, hypoxia-inducible factor-1α expression was increased intracellularly after cold atmospheric plasma treatment, which further bound to the promoter region of gene and enhanced MANF transcriptional expression. This study reveals that cold atmospheric plasma has a positive effect on atopic dermatitis treatment, also demonstrates the regulatory mechanism of cold atmospheric plasma on MANF expression HIF-1α, which indicates the potential medical application of cold atmospheric plasma for atopic dermatitis treatment.
低温大气压等离子体在医学治疗中得到了广泛的应用,尤其是在皮肤病治疗方面。然而,低温大气压等离子体治疗皮肤病的机制仍未明确。在本研究中,构建了二硝基氟苯诱导的特应性皮炎小鼠模型。低温大气压等离子体能够减少皮肤细胞凋亡,缓解二硝基氟苯刺激引起的皮肤炎症、内质网应激和氧化应激,这一作用是通过低温大气压等离子体诱导 MANF 表达介导的。就其机制而言,低温大气压等离子体处理后细胞内缺氧诱导因子-1α的表达增加,进而与 基因的启动子区域结合,增强 MANF 的转录表达。本研究揭示了低温大气压等离子体对特应性皮炎治疗具有积极作用,同时也证明了低温大气压等离子体对 MANF 表达的调控机制,即 HIF-1α,这表明低温大气压等离子体在特应性皮炎治疗方面具有潜在的医学应用价值。